VisEn unveils new molecular imaging agent

11/12/2009 | Yahoo!

VisEn Medical has introduced its Cat B 750 FAST imaging agent for tracking the activity of cathepsin B expression, an important biomarker and drug target for several diseases, including atherosclerosis and arthritis. The new agent is designed to enhance in vitro and in vivo protease readouts from cell-based assays and the company's portfolio of in vivo agents.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC